US Executive Compensation Proxy SEC Filings — June 22, 2026

22-06-2026

Albertsons Companies filed its 2026 Proxy Statement (DEF 14A) for the upcoming virtual-only Annual Meeting of Stockholders on August 6, 2026. The filing includes 10 director nominees, proposals to eliminate supermajority voting requirements and limit officer liability, and an advisory vote on executive compensation. The company reported strong stockholder support (97% say-on-pay approval in 2025) and notes that 90% of CEO target compensation is variable/at-risk, but also highlights a relatively new board with an average tenure of only 4.3 years and 50% of directors serving less than 3 years.

• · Annual Meeting is virtual-only, held on August 6, 2026 at 8:00 a.m. Mountain Daylight Time
• · Record date for voting is June 9, 2026
• · Proposal 4 seeks to eliminate supermajority voting requirements from the Certificate of Incorporation
• · Proposal 5 seeks to limit liability of officers as permitted by Delaware law (exculpation)
• · Proposal 6 is a stockholder proposal requesting a report on human rights policy and due diligence process — Board recommends voting AGAINST
• · 50% of director nominees have served less than 3 years on the board
• · 30% of director nominees are over 70 years of age
• · All 10 director nominees have financial literacy/expertise and risk management skills
• · Only 2 of 10 director nominees have information technology and cybersecurity expertise
• · The Compensation Committee did not make direct changes to compensation programs following the 97% say-on-pay vote

22-06-2026

Jupiter Neurosciences, Inc. filed its definitive proxy statement (DEF 14A) for the 2026 Annual Meeting of Stockholders, to be held virtually on July 22, 2026. The meeting will include the election of seven directors, ratification of Cherry Bekaert as independent auditor for FY2026, an amendment to the 2025 Plan to increase authorized shares by 5,250,000, and an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1:10 and 1:100. As of the June 15, 2026 record date, there were 48,224,110 shares of common stock outstanding.

• · The Annual Meeting will be held virtually on July 22, 2026, at 10:00 a.m. Eastern Time, accessible at https://edge.media-server.com/mmc/p/s8ptz3m9.
• · Proposal 1: Election of seven directors to serve until the 2027 annual meeting.
• · Proposal 2: Ratification of Cherry Bekaert as independent registered public accounting firm for fiscal year ending December 31, 2026.
• · Proposal 3: Amendment to 2025 Plan to increase authorized shares by 5,250,000 shares of common stock.
• · Proposal 4: Amendment to Certificate of Incorporation to effect a reverse stock split at a ratio of not less than 1:10 and not more than 1:100, with timing and ratio at Board's discretion.
• · The record date for voting is June 15, 2026.
• · Stockholders may vote via Internet, telephone, or mail by July 21, 2026.
• · Only common stock is outstanding; no other voting shares exist.

22-06-2026

Vicarious Surgical Inc. is soliciting stockholder approval for an assignment for the benefit of creditors followed by voluntary dissolution and liquidation, effectively winding down the company. The special meeting is scheduled for July 21, 2026, with a record date of June 10, 2026, and 7,131,355 shares of common stock outstanding and entitled to vote. The board recommends a 'FOR' vote, but warns that the timing and amount of any distributions to stockholders are uncertain and cannot be assured.

• · Each share of Class A common stock entitles the holder to 1 vote; each share of Class B common stock entitles the holder to 20 votes.
• · The affirmative vote of at least a majority in voting power of outstanding common stock is required to approve the proposal.
• · The board retains discretion to abandon the assignment and dissolution at any time.
• · The company expects the proposal to be considered a non-routine matter, so broker non-votes are not expected.
• · Preliminary voting results will be announced at the special meeting, and final results will be filed on Form 8-K within four business days.

22-06-2026

Park Aerospace Corp. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Shareholders to be held virtually on July 21, 2026. The meeting will include election of six directors, an advisory vote on executive compensation, and ratification of CohnReznick LLP as auditor. CEO Brian E. Shore's compensation actually paid (CAP) increased significantly to $1,033,654 in fiscal 2026 from $166,554 in fiscal 2025, while average CAP for other NEOs rose to $666,353 from $219,779, reflecting improved performance metrics.

• · Annual Meeting will be held virtually on July 21, 2026 at 11:00 AM EDT via meetnow.global/MMJ99GX.
• · Record date for voting is June 1, 2026.
• · Shareholders must register by July 16, 2026 if holding through a broker.
• · Proposals include election of six directors, advisory vote on executive compensation, and ratification of auditor.
• · The company determined Adjusted EBITDA as a core driver of performance and shareholder value creation for 2026.

22-06-2026

NVE Corporation filed its DEF 14A proxy statement for the 2026 Annual Meeting scheduled for August 6, 2026. The filing includes proposals to elect directors, an advisory vote on executive compensation, and ratification of the independent auditor. Key financial data shows 4,837,166 shares outstanding as of June 12, 2026, with major shareholders including Defiance ETFs (12.0%), BlackRock (7.7%), and Vanguard (5.0%). The company reported no related-party transactions in the past two fiscal years.

• · Annual Meeting to be held on August 6, 2026 at 3:30 p.m. Central Daylight Time at 11409 Valley View Road, Eden Prairie, Minnesota.
• · Proxy statement first mailed or made accessible on or about June 22, 2026.
• · Record date for voting is June 12, 2026.
• · Shareholder proposals for inclusion in proxy statement must have been received by February 23, 2026; no such proposals were received.
• · Equity compensation plan information: 37,500 options outstanding with weighted-average exercise price of $72.86; 113,240 shares available for future issuance.
• · No related-party transactions in the past two fiscal years.

22-06-2026

Treasure Global Inc (TGL) filed a definitive proxy statement (DEF 14A) on June 22, 2026, for its 2026 Annual Meeting of Stockholders to be held virtually on July 14, 2026. The meeting will include the election of seven directors and the ratification of WWC, P.C. as independent auditor for the fiscal year ending July 14, 2026. The filing also notes that the company primarily distributes proxy materials over the internet and provides details on virtual attendance and voting procedures.

• · The record date for stockholders entitled to vote is June 10, 2026.
• · The 2025 Annual Report (Form 10-K) accompanies the proxy statement.
• · Proxy materials are first made available on or about June 22, 2026 at https://web.viewproxy.com/tgl/2026.
• · Stockholders can vote over the internet, by telephone, or by mailing a proxy card.
• · The company is incorporated in Delaware with a fiscal year ending June 30.
• · Standard Industrial Classification: Services-Business Services, NEC (7389).

22-06-2026

Linkhome Holdings Inc. is holding its Annual Meeting on July 15, 2026, with 16,230,000 shares outstanding as of the June 12, 2026 record date. Key proposals include electing six directors, ratifying Simon & Edward, LLP as auditor, adopting the 2026 Equity Incentive Plan, and authorizing a reverse stock split (1-for-5 to 1-for-20). The Board recommends a 'FOR' vote on all proposals.

• · Annual Meeting will be held virtually via live audio webcast on July 15, 2026 at 11:00 a.m. Pacific Time.
• · Record date for voting is June 12, 2026.
• · Proposal No. 4 authorizes a reverse stock split with a ratio range of 1-for-5 to 1-for-20, to be implemented within one year of approval.
• · Proxies will be first mailed to stockholders on or about June 23, 2026.
• · The 2025 Annual Report was filed with the SEC on March 26, 2026, as amended on May 19, 2026.

22-06-2026

System1, Inc. filed a DEF 14A proxy statement for its 2026 annual meeting of stockholders to be held virtually on July 22, 2026. The meeting will include three proposals: approval of the issuance of Series A Cumulative Convertible Preferred Shares to comply with NYSE listing rules, election of three Class I directors, and ratification of Deloitte & Touche LLP as independent auditor for fiscal year 2026. The board recommends a vote 'FOR' all proposals.

• · Annual meeting will be held virtually on July 22, 2026 at 11:00 a.m. Pacific Time.
• · Record date for voting is June 18, 2026.
• · Proxy materials first mailed on or about June 23, 2026.
• · Proposal 1 requires approval of majority of votes cast for issuance of Preferred Shares under NYSE rules.
• · Proposal 2: election of three Class I directors by plurality vote.
• · Proposal 3: ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.
• · No fee required for filing; proxy solicitation expenses borne by the Company.
• · Potential proxy solicitation firm fees estimated up to $25,000 plus out-of-pocket expenses.

22-06-2026

Versus Systems Inc. filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Shareholders to be held virtually on July 16, 2026. The meeting will include the election of four director nominees (Luis Goldner, Aric Spitulnik, David Catzel, Juan Carlos Barrera) and a proposal to adjourn if needed. As of the May 26, 2026 record date, the company had only 4,901,677 shares outstanding and approximately 80 registered shareholders, reflecting a very small shareholder base.

• · The annual meeting will be held virtually at meetnow.global/MZGLQVW on July 16, 2026 at 10:30 a.m. Eastern time.
• · Shareholders of record as of May 26, 2026 are entitled to vote.
• · A quorum requires at least 50% plus one share of outstanding shares (over 2,450,839 shares) present in person or by proxy.
• · Directors are elected by a plurality vote; the adjournment proposal requires a majority of votes cast.
• · Luis Goldner also serves as Principal Financial Officer since January 2026.
• · Aric Spitulnik previously oversaw a budget of $1.2 billion in revenue and 7,000 employees as senior vice president.
• · The proxy statement was first mailed to shareholders on or about June 5, 2026.

22-06-2026

Professional Diversity Network, Inc. (IPDN) filed a DEF 14A proxy statement on June 22, 2026, seeking stockholder approval for a reverse stock split to regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share, after receiving a Nasdaq notice on June 5, 2026. The company has until December 2, 2026, to regain compliance, and the board may set the reverse split ratio within a range to be determined. However, the filing acknowledges that the reverse split may not increase the stock price as desired, could decrease liquidity, and the company may still face delisting if other Nasdaq requirements are not met.

• · The reverse stock split will not change the number of authorized shares or par value of Common Stock.
• · The board may implement the reverse split at any time within one year of stockholder approval.
• · If implemented, the reverse split will become effective at 5:30 p.m. Eastern Time on the filing date of the charter amendment.
• · The company may still be delisted if it fails to meet other Nasdaq requirements, such as minimum stockholders' equity, public float, market value of public float, or number of round lot holders.
• · The reverse split could have an anti-takeover effect due to increased proportion of unissued authorized shares, though the board does not intend such an effect.

22-06-2026

Milestone Scientific Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting, nominating five directors for election: Benedetta Casamento (Chairman), Neal Goldman (Vice Chairman), Eric Hines (CEO), Dr. Didier Demesmin, and Dr. Dawood Sayed. Director Shanth Thiyagalingam is not seeking re-election. The board highlights a leadership structure with separate Chairman and CEO roles, and oversees risks including operations in China, liquidity, and market acceptance of medical products.

• · The Board has three standing committees: Audit, Compensation, and Nominating and Corporate Governance.
• · Risks identified include operations in China, liquidity and access to capital, market acceptance of medical products, and regulatory matters.
• · Director nominees: Benedetta Casamento (age 59, director since 2022), Neal Goldman (81, since 2019), Eric Hines (58, since 2025), Dr. Didier Demesmin (56, since 2024), Dr. Dawood Sayed (46, since 2025).
• · Shanth Thiyagalingam is not standing for re-election, creating a vacancy.
• · Eric Hines became President and CEO on July 31, 2025.